首页> 外文OA文献 >Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125

【2h】

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125

机译：通过与已建立的标记CA125进行比较评价卵巢癌缓解标记物HE4，MMP7和MESOTHELIN

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Michèl Schummer; Charles Drescher; Robin Forrest; Shirley Gough; Jason Thorpe; Ingegerd Hellström; Karl Erik Hellström; Nicole Urban;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 [J] . SchummerM., DrescherC., ForrestR., Gynecologic Oncology: An International Journal . 2012,第1期

机译：与已建立的标志物CA125相比，评估卵巢癌缓解标志物HE4，MMP7和间皮素
2. Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125 [J] . McKinnon Brett, Mueller Michael D., Nirgianakis Konstantinos, Molecular medicine reports . 2015,第4aPta1期

机译：子宫内膜异位症中卵巢癌标志物的比较偏爱HE4而非CA125
3. Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4 [J] . Daniel J O’Shannessy, Elizabeth B Somers, Leslie M Palmer, Journal of Ovarian Research . 2013,第1期

机译：卵巢癌中的血清叶酸受体α，间皮素和巨核细胞增强因子：与疾病阶段和等级的关联以及与CA125和HE4的比较
4. Interferometric detection of early markers for epithelial ovarian cancer and prognostic markers for acute lymphocytic leukemia [C] . P. ONeil, M. Zhao, X. Wang, Advanced biomedical and clinical diagnostic systems VIII . 2010

机译：干涉法检测上皮性卵巢癌的早期标志物和急性淋巴细胞白血病的预后标志物
5. Role of ovarian cancer antigen CA125/MUC16 in development and cancer. [D] . Cheon, Dong-Joo (Ellen). 2009

机译：卵巢癌抗原CA125 / MUC16在发育和癌症中的作用。
6. Evaluation of ovarian cancer remission markers HE4 MMP7 and Mesothelin by comparison to the established marker CA125 [O] . Michèl Schummer, Charles Drescher, Robin Forrest, -1

机译：的卵巢癌标志物缓解HE4mmp7和间皮素的评价通过比较所建立的标记物Ca125
7. Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125 [O] . Mc Kinnon, Brett, Mueller, Michael, Nirgianakis, Konstantinos, 2015

机译：子宫内膜异位症中卵巢癌标志物的比较偏爱HE4而非CA125
8. Tumor Marker CA 125: The Clinical Significance of the Serum Marker CA 125 in the Management of Patients with Ovarian Cancer [R] . van der Burg, M. E. L. 1989

机译：肿瘤标志物Ca 125：血清标志物Ca 125在卵巢癌患者管理中的临床意义

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125

著录项

引文网络

相似文献

相关主题

期刊订阅